Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development

Cell Transplantation

Volumn 25, Issue 1, 2016, Pages 1-15

  Jang, Eunkyeong ^a   Jeong, Mini ^a   Kim, Sukhyung ^a   Jang, Kiseok ^a   Kang, Bo Kyeong ^a   Lee, Dong Yun ^a   Bae, Sang Cheol ^b   Kim, Kyung Suk ^c   Youn, Jeehee ^a  

^a Hanyang University   (South Korea)

^b Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^c Division of Dg and Ai Business   (South Korea)

Author keywords

Autoimmunity; Follicular helper T (Tfh) cells; Mesenchymal stem cells (MSCs); Nephritis; Systemic lupus erythematosus (SLE)

Indexed keywords

AUTOANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEPHRITIS; NEW ZEALAND BLACK MOUSE; NEW ZEALAND WHITE MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GERMINAL CENTER; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LUPUS NEPHRITIS; LYMPH NODE; MESENCHYMAL STROMA CELL; PATHOLOGY;

ANIMALS; AUTOANTIBODIES; BONE MARROW CELLS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; GERMINAL CENTER; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; LUPUS NEPHRITIS; LYMPH NODES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICE, INBRED NZB; PLASMA CELLS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84954516154     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X688173     Document Type: Article

References (47)

1. Asari, S.; Itakura, S.; Ferreri, K.; Liu, C. P.; Kuroda, Y.; Kandeel, F.; Mullen, Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 37(5):604-615; 2009.
2. Augello, A.; Tasso, R.; Negrini, S. M.; Amateis, A.; Indiveri, F.; Cancedda, R.; Pennesi, G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35(5):1482-1490; 2005.
3. Brady, M. T.; Hilchey, S. P.; Hyrien, O.; Spence, S. A.; Bernstein, S. H. Mesenchymal stromal cells support the viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells. PLoS One 9(5):e97597; 2014.
4. Cappione, A.; Anolik, J. H.; Pugh-Bernard, A.; Barnard, J.; Dutcher, P.; Silverman, G.; Sanz, I. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115(11):3205-3216; 2005.
5. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20(2):245-257; 2011.
6. Choi, E. W.; Shin, I. S.; Park, S. Y.; Park, J. H.; Kim, J. S.; Yoon, E. J.; Kang, S. K.; Ra, J. C.; Hong, S. H. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum. 64(1):243-253; 2012.
7. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367-372; 2006.
8. Craft, J. E. Follicular helper T cells in immunity and systemic autoimmunity. Nat. Rev. Rheumatol. 8(6):337-347; 2012.
9. Der, E.; Dimo, J.; Trigunaite, A.; Jones, J.; Jorgensen, T. N. Gr1+ cells suppress T-dependent antibody responses in (NZB x NZW)F1 male mice through inhibition of T follicular helper cells and germinal center formation. J. Immunol. 192(4):1570-1576; 2014.
10. Dong, W.; Zhu, P.; Wang, Y.; Wang, Z. Follicular helper T cells in systemic lupus erythematosus: A potential therapeutic target. Autoimmun. Rev. 10(6):299-304; 2011.
11. Feng, X.; Wang, D.; Chen, J.; Lu, L.; Hua, B.; Li, X.; Tsao, B. P.; Sun, L. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One 7(12):e51982; 2012.
12. Gu, Z.; Akiyama, K.; Ma, X.; Zhang, H.; Feng, X.; Yao, G.; Hou, Y.; Lu, L.; Gilkeson, G. S.; Silver, R. M.; Zeng, X.; Shi, S.; Sun, L. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19(13):1502-1514; 2010.
13. Hams, E.; McCarron, M. J.; Amu, S.; Yagita, H.; Azuma, M.; Chen, L.; Fallon, P. G. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells. J. Immunol. 186(10):5648-5655; 2011.
14. Jang, E.; Cho, W. S.; Cho, M. L.; Park, H. J.; Oh, H. J.; Kang, S. M.; Paik, D. J.; Youn, J. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol. 186(3):1546-1553; 2011.
15. Jung, M. J.; Lee, S. S.; Hwang, Y. H.; Jung, H. S.; Hwang, J. W.; Kim, M. J.; Yoon, S.; Lee, D. Y. MRI of transplanted surface-labeled pancreatic islets with heparinized superparamagnetic iron oxide nanoparticles. Biomaterials 32(35):9391-9400; 2011.
16. Kang, S. M.; Jang, E.; Paik, D. J.; Jang, Y. J.; Youn, J. CD4+CD25+ regulatory T cells selectively diminish systemic autoreactivity in arthritic K/BxN mice. Mol. Cells 25(1):64-69; 2008.
17. Kim, C. H.; Rott, L. S.; Clark-Lewis, I.; Campbell, D. J.; Wu, L.; Butcher, E. C. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193(12):1373-1381; 2001.
18. Kim, H. J.; Verbinnen, B.; Tang, X.; Lu, L.; Cantor, H. Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 467(7313):328-332; 2010.
19. Langenkamp, A.; Nagata, K.; Murphy, K.; Wu, L.; Lanzavecchia, A.; Sallusto, F. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur. J. Immunol. 33(2):474-482; 2003.
20. Le Coz, C.; Joublin, A.; Pasquali, J. L.; Korganow, A. S.; Dumortier, H.; Monneaux, F. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One 8(9):e75319; 2013.
21. Linterman, M. A.; Rigby, R. J.; Wong, R. K.; Yu, D.; Brink, R.; Cannons, J. L.; Schwartzberg, P. L.; Cook, M. C.; Walters, G. D.; Vinuesa, C. G. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206(3):561-576; 2009.
22. Lu, K. T.; Kanno, Y.; Cannons, J. L.; Handon, R.; Bible, P.; Elkahloun, A. G.; Anderson, S. M.; Wei, L.; Sun, H.; O’Shea, J. J.; Schwartzberg, P. L. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 35(4):622-632; 2011.
23. Ma, X.; Che, N.; Gu, Z.; Huang, J.; Wang, D.; Liang, J.; Hou, Y.; Gilkeson, G.; Lu, L.; Sun, L. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 22(12):2279-2290; 2013.
24. Makino, Y.; Yamaza, H.; Akiyama, K.; Ma, L.; Hoshino, Y.; Nonaka, K.; Terada, Y.; Kukita, T.; Shi, S.; Yamaza, T. Immune therapeutic potential of stem cells from human supernumerary teeth. J. Dent. Res. 92(7):609-615; 2013.
25. Pathak, S.; Mohan, C. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res. Ther. 13(5):241; 2011.
26. Radbruch, A.; Muehlinghaus, G.; Luger, E. O.; Inamine, A.; Smith, K. G.; Dorner, T.; Hiepe, F. Competence and competition: The challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6(10):741-750; 2006.
27. Rahman, A.; Isenberg, D. A. Systemic lupus erythematosus. N. Engl. J. Med. 358(9):929-939; 2008.
28. Ren, G.; Chen, X.; Dong, F.; Li, W.; Ren, X.; Zhang, Y.; Shi, Y. Concise review: Mesenchymal stem cells and translational medicine: Emerging issues. Stem Cells Transl. Med. 1(1):51-58; 2012.
29. Sang, A.; Yin, Y.; Zheng, Y. Y.; Morel, L. Animal models of molecular pathology systemic lupus erythematosus. Prog. Mol. Biol. Transl. Sci. 105:321-370; 2012.
30. Schena, F.; Gambini, C.; Gregorio, A.; Mosconi, M.; Reverberi, D.; Gattorno, M.; Casazza, S.; Uccelli, A.; Moretta, L.; Martini, A.; Traggiai, E. Interferon-gammadependent inhibition of B cell activation by bone marrow- derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62(9): 2776-2786; 2010.
31. Simpson, N.; Gatenby, P. A.; Wilson, A.; Malik, S.; Fulcher, D. A.; Tangye, S. G.; Manku, H.; Vyse, T. J.; Roncador, G.; Huttley, G. A.; Goodnow, C. C.; Vinuesa, C. G.; Cook, M. C. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 62(1):234-244; 2010.
32. Singer, N. G.; Caplan, A. I. Mesenchymal stem cells: Mechanisms of inflammation. Annu. Rev. Pathol. 6:457-478; 2011.
33. Slifka, M. K.; Antia, R.; Whitmire, J. K.; Ahmed, R. Humoral immunity due to long-lived plasma cells. Immunity 8(3):363-372; 1998.
34. Strioga, M.; Viswanathan, S.; Darinskas, A.; Slaby, O.; Michalek, J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 21(14):2724-2752; 2012.
35. Sun, L.; Akiyama, K.; Zhang, H.; Yamaza, T.; Hou, Y.; Zhao, S.; Xu, T.; Le, A.; Shi, S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421-1432; 2009.
36. Sun, L.; Wang, D.; Liang, J.; Zhang, H.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Ye, S.; Hu, X.; Xu, W.; Zeng, X.; Hou, Y.; Gilkeson, G. S.; Silver, R. M.; Lu, L.; Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62(8):2467-2475; 2010.
37. Tabera, S.; Perez-Simon, J. A.; Diez-Campelo, M.; Sanchez-Abarca, L. I.; Blanco, B.; Lopez, A.; Benito, A.; Ocio, E.; Sanchez-Guijo, F. M.; Canizo, C.; San Miguel, J. F. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93(9):1301-1309; 2008.
38. Tangye, S. G.; Ma, C. S.; Brink, R.; Deenick, E. K. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 13(6):412-426; 2013.
39. Terrier, B.; Costedoat-Chalumeau, N.; Garrido, M.; Geri, G.; Rosenzwajg, M.; Musset, L.; Klatzmann, D.; Saadoun, D.; Cacoub, P. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. J. Rheumatol. 39(9):1819-1828; 2012.
40. Traggiai, E.; Volpi, S.; Schena, F.; Gattorno, M.; Ferlito, F.; Moretta, L.; Martini, A. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 26(2):562-569; 2008.
41. Vinuesa, C. G.; Sanz, I.; Cook, M. C. Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 9(12):845-857; 2009.
42. Wang, D.; Feng, X.; Lu, L.; Konkel, J. E.; Zhang, H.; Chen, Z.; Li, X.; Gao, X.; Lu, L.; Shi, S.; Chen, W.; Sun, L. A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus. Arthritis Rheumatol. 66(8):2234-2245; 2014.
43. Wang, D.; Zhang, H.; Liang, J.; Li, X.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Lu, L.; Gilkeson, G. S. Silver, R. M.; Chen, W.; Shi, S.; Sun, L. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 22(12):2267-2277; 2013.
44. Xu, J.; Wang, D.; Liu, D.; Fan, Z.; Zhang, H.; Liu, O.; Ding, G.; Gao, R.; Zhang, C.; Ding, Y.; Bromberg, J. S.; Chen, W.; Sun, L.; Wang, S. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 120(15):3142-3151; 2012.
45. Yang, X.; Yang, J.; Chu, Y.; Wang, J.; Guan, M.; Zhu, X.; Xue, Y.; Zou, H. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice. PLoS One 8(4):e62855; 2013.
46. Youd, M.; Blickarz, C.; Woodworth, L.; Touzjian, T.; Edling, A.; Tedstone, J.; Ruzek, M.; Tubo, R.; Kaplan, J.; Lodie, T. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol. 161(1):176-186; 2010.
47. Zhou, K.; Zhang, H.; Jin, O.; Feng, X.; Yao, G.; Hou, Y.; Sun, L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5(6):417-424; 2008.